Real-World Clinical Experience of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Olaparib + Abiraterone (PROceed)

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Country	Location
Germany	Aschaffenburg, Germany
Germany	Augsburg, Germany
Germany	Bergisch Gladbach, Germany
Germany	Berlin, Germany
Germany	Bonn, Germany
Germany	Dresden, Germany
Germany	Duisburg, Germany
Germany	Eisenach, Germany
Germany	Frankfurt, Germany
Germany	Greifswald, Germany
Germany	Halle, Germany
Germany	Hamburg, Germany
Germany	Hannover, Germany
Germany	Heidelberg, Germany
Germany	Heinsberg, Germany
Germany	Herzogenaurach, Germany
Germany	Koln, Germany
Germany	Leipzig, Germany
Germany	Luebeck, Germany
Germany	Luneburg, Germany
Germany	Lutherstadt Eisleben, Germany
Germany	Magdeburg, Germany
Germany	Marburg, Germany
Germany	Muelheim, Germany
Germany	Munster, Germany
Germany	Neunkirchen, Germany
Germany	Nurnberg, Germany
Germany	Ruesselsheim, Germany
Germany	Saalfeld, Germany
Germany	Speyer, Germany
Germany	Trier, Germany
Germany	Tuebingen, Germany
Germany	Westerstede, Germany
Germany	Wetzlar, Germany